Boothbay Fund Management »

Cidara Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Cidara Therapeutics (CDTX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Cidara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cidara Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cidara Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.8M 102k 95.76
2025-06-30 $22M 454k 48.71
2025-03-31 $1.7M 79k 21.54
2024-12-31 $419k 16k 26.88

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Cidara Therapeutics

RA Capital Management
Bain Capital Life Sciences Investors
Point72 Asset Management
BVF
Vivo Capital
Vanguard Group
BlackRock
Darwin Global Management
Paradigm Biocapital Advisors
VR Adviser
Morgan Stanley
FMR
State Street Corporation
Citadel Advisors
Henderson Group

View all funds holding Cidara Therapeutics